"For about a year now, patients with insane diabetes warn that the Gensulin Nsulin of the Bioton is poor quality. However, the answers were not only worrisome, but also puzzling and ridiculous, "said Anush Poghosyan, President of the NGO.
He details.
"It was first discovered that the Thai Health Ministry refused to substantiate that negative deviations were recorded in the laboratory of patients in the 33rd month of study, as a result of the quality of Gensulin.
Since the beginning of the Republic of Armenia, they denied the fact, when the documents of the Thai Ministry of Health were published, they clarified the quality of the transformation of Gensulin N in Poland, which did not pass clinical trials. And so,
1. About 70% of patients have been unprecedented high, patients at least 70% of patients with disabilities, especially in the effects of eyes, kidneys, nerves, heart and blood vessels, dysfunction and deficiency, which undermines. The consistency and continuity of the disease management, leading to the growth of the population and the growth of disability, which significantly increases the health care costs.
2. The insufficient efficiency of Gensulin N brings an increase in doses, as a result of which the volume of procurement will increase dramatically.
As a result, state funds are being poorly. Getting this insulin and have to buy another insulin, spending a month to 20000 AMD.
I urge the relevant authorities to ask the RA Minister the following issues:
1. Why do this insulin side effects hide and what is his interest when patients with insulin debridal diabetes are slowly troubled?
2. Did they register what part of the population?
3. Inquired the skills of the non-efficiency and consequences of the use of Gensulin N.
4. How did gensulin n purchase have been made and that the Armenian laboratory has fulfilled the Formula test (tip, there is no such laboratory). "
